Khan, Zeba M.; Rascati, Karen L.; Koeller, Jim M. - In: PharmacoEconomics 16 (1999) 1, pp. 43-57
Objective: To conduct an economic analysis on the use of carboplatin versus cisplatin over multiple courses in patients with lung [nonsmall cell lung cancer (NSCLC) and small cell lung cancer (SCLC)] or ovarian cancer. Design: This 1-year study was a prospective, multicentre, cost-minimisation...